Targeted therapy with galantamine in a pediatric patient with 15q13.3 deletion syndrome


Por: Casas-Alba D, Nolasco-Tovar GA, Díez M, Mezzatesta M, Balañá G and Fons-Estupina C

Publicada: 1 dic 2021 Ahead of Print: 1 jul 2021
Resumen:


Filiaciones:
Casas-Alba D:
 Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Pediatric Neurology Department, Hospital Sant Joan de Déu, Barcelona, Spain

Nolasco-Tovar GA:
 Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Pediatric Neurology Department, Hospital Sant Joan de Déu, Barcelona, Spain

Díez M:
 Child and Adolescent Mental Health Area, Hospital Sant Joan de Déu, Barcelona, Spain

 Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Mezzatesta M:
 Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Child and Adolescent Mental Health Area, Hospital Sant Joan de Déu, Barcelona, Spain

Balañá G:
 Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Child and Adolescent Mental Health Area, Hospital Sant Joan de Déu, Barcelona, Spain

Fons-Estupina C:
 Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Pediatric Neurology Department, Hospital Sant Joan de Déu, Barcelona, Spain

 Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
ISSN: 15524825





AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ, Estados Unidos America
Tipo de documento: Letter
Volumen: 185 Número: 12
Páginas: 3897-3899
WOS Id: 000673369000001
ID de PubMed: 34272916

MÉTRICAS